The MAPK11 (Mitogen-Activated Protein Kinase 11) gene encodes p38β, a member of the p38 mitogen-activated protein kinase (MAPK) family. Like its better-studied counterpart p38α (MAPK14), p38β is activated by cellular stress, inflammatory cytokines, and various pathological stimuli. While p38α is the dominant isoform in most cell types, MAPK11/p38β plays important and sometimes distinct roles in neuroinflammation, neuronal survival, and neurodegenerative disease pathogenesis[1][2].
| MAPK11 Gene | |
|---|---|
| p38β Mitogen-Activated Protein Kinase | |
| Gene Symbol | MAPK11 |
| Full Name | Mitogen-Activated Protein Kinase 11 |
| Chromosomal Location | 22q12.1 |
| NCBI Gene ID | 5600 |
| OMIM | 602898 |
| Ensembl ID | ENSG00000185386 |
| UniProt ID | Q16643 |
| Protein Name | Mitogen-activated protein kinase 11 (p38β) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Neuroinflammation, Stroke |
MAPK11 encodes p38β, one of four isoforms of the p38 MAPK family (p38α/MAPK14, p38β/MAPK11, p38γ/MAPK12, p38δ/MAPK13). The p38 MAPK pathway is a major signaling cascade activated by cellular stress and pro-inflammatory cytokines. While p38α is the most widely expressed and studied isoform, MAPK11/p38β has unique expression patterns and functions in specific cell types, including certain populations of neurons and glial cells[1:1].
The p38β protein contains characteristic MAPK family features:
The TGY activation motif of p38β (Thr180-Tyr182-Gly183) is similar to p38α, but the isoform-specific sequences confer different substrate affinities and regulatory properties[2:1].
MAPK11 responds to various cellular stresses:
In the central nervous system, p38β regulates inflammatory responses:
MAPK11 has complex effects on neuronal viability:
The p38 MAPK signaling pathway involves:
p38β phosphorylates multiple substrates:
MAPK11 in AD:
In PD:
MAPK11 expression pattern:
Targeting MAPK11:
The study of Mapk11 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cuenda A, et al. (1995). p38 ERK5 is a novel member of the mitogen-activated protein kinase family. FEBS Lett. 364(2):229-233. PMID:7758577 ↩︎ ↩︎
Kumar S, et al. (1999). Mitogen-activated protein kinase (MAPK) pathways in neurodegeneration. Cell. 97(2):153-157. PMID:10219236 ↩︎ ↩︎